Cable Hill Partners’s NanoViricides NNVC Stock Holding History

Cable Hill Partners’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-36	Closed	-$1K	–	698
2015 Q3	$1K	Hold	36	–	–	﹤0.01%	669
2015 Q2	$2K	Hold	36	–	–	﹤0.01%	668
2015 Q1	$2K	Hold	36	–	–	﹤0.01%	668
2014 Q4	$2K	Buy	+36	New	+$2.38K	﹤0.01%	641

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SIP

Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cable Hill Partners's NNVC Position: Q4 2015 in Review

Cable Hill Partners sold out of NanoViricides (NNVC) in Q4 2015, closing a stake of 36 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in NNVC in Q4 2014 and held it in 4 quarters. The position peaked at $2K in Q2 2015. 41 funds tracked by Wall St. Rank hold NNVC as of Q4 2015.

Cable Hill Partners reported no remaining NanoViricides position as of Q4 2015 after selling out during the quarter.
Cable Hill Partners sold 36 NanoViricides shares in Q4 2015, an estimated $1K.
Cable Hill Partners first reported a position in NanoViricides in Q4 2014 and held it in 4 quarters.
Cable Hill Partners's NanoViricides position peaked at $2K in Q2 2015.
41 funds tracked by Wall St. Rank held NanoViricides as of Q4 2015.

Based on Cable Hill Partners's 13F filing for Q4 2015, filed 5 Aug 2016.